Xinfeng Yang

Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy

Caicun Zhou, Yina Wang, Jun Zhao et al. · Clinical Cancer Research · 2021 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17

Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

Ning Li, Youzhong Zhang, Jing Wang et al. · Journal of Clinical Oncology · 2022 · 73 citations

Medicine, Oncology, Pharmacology +15

Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial

Weijie Gu, Weiqing Han, Hong Luo et al. · The Lancet Oncology · 2022 · 66 citations

Medicine, Oncology, Urology +16

An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline <i>BRCA1/2</i> Mutation and Platinum-sensitive Recurrent Ovarian Cancer

Ning Li, Hualei Bu, Jihong Liu et al. · Clinical Cancer Research · 2021 · 55 citations · Full text

Medicine, Oncology, Pharmacology +13

Reversibly highly stretchable and self‐healable zwitterion‐containing polyelectrolyte hydrogel with high ionic conductivity for high‐performance flexible and cold‐resistant supercapacitor

Wenjing Diao, Linlin Wu, Xiaofeng Ma et al. · Journal of Applied Polymer Science · 2020 · 47 citations

Natural Sciences, Materials Engineering, Materials Science +17